Trial site
MD Anderson Cancer Center
- 434running trials
- 165closed trials
The trials here
What the 605 trials at this site are about, from their registry records.
- Conditions
- Lung cancer122 trials
- Colorectal cancer95 trials
- Childhood cancers76 trials
- Ovarian cancer63 trials
- Acute myeloid leukaemia58 trials
- Pancreatic cancer57 trials
- Head and neck cancer49 trials
- Gastric and oesophageal cancer47 trials
- Prostate cancer43 trials
- Melanoma41 trials
- Liver and biliary tract cancer40 trials
- Sarcoma40 trials
- and 44 more
- Phase
- Phase 1193 trials
- Phase 2132 trials
- Phase 1/2128 trials
- Phase 363 trials
- Phase 2/37 trials
- Phase 44 trials
- Early phase 11 trial
- Status
- Recruiting251 trials
- Active, not recruiting160 trials
- Completed84 trials
- Terminated74 trials
- Not yet recruiting21 trials
- Withdrawn7 trials
- Suspended6 trials
- Enrolling by invitation2 trials
- Lead sponsor
- M.D. Anderson Cancer Center137 trials
- Janssen Research & Development, LLC19 trials
- Incyte Corporation16 trials
- Hoffmann-La Roche13 trials
- Eli Lilly and Company9 trials
- and 293 more
Running trials
Not yet recruiting
Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms
Not yet recruiting
Not yet recruiting
RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
A Study of LY4336619 in Adult Participants With Advanced Solid Tumors
Not yet recruiting
Not yet recruiting
Recruiting
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
Not yet recruiting
Recruiting
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
Recruiting
Recruiting
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
Not yet recruiting
Recruiting
Recruiting
Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Recruiting
A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
Recruiting
Recruiting
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Recruiting
Recruiting
Recruiting
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Recruiting
Recruiting
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
Recruiting
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
Recruiting
Recruiting
Recruiting
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC
Recruiting
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Showing 50 of 434.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer50 recruiting
- Colorectal cancer48 recruiting
- Childhood cancers33 recruiting
- Acute myeloid leukaemia29 recruiting
- Ovarian cancer25 recruiting
- Prostate cancer24 recruiting
- Gastric and oesophageal cancer23 recruiting
- Head and neck cancer21 recruiting
- Sarcoma20 recruiting
- Pancreatic cancer19 recruiting
- Liver and biliary tract cancer16 recruiting
- Myelodysplastic syndromes16 recruiting
- Bladder cancer14 recruiting
- Endometrial cancer14 recruiting
- Kidney cancer14 recruiting
- Melanoma14 recruiting
- Myeloproliferative neoplasms12 recruiting
- Triple-negative breast cancer12 recruiting
- Multiple myeloma11 recruiting
- Thyroid cancer11 recruiting
- Acute lymphoblastic leukaemia9 recruiting
- Cervical cancer9 recruiting
- Chronic myeloid leukaemia9 recruiting
- Diffuse large B-cell lymphoma7 recruiting
- Mesothelioma7 recruiting
- Metastatic breast cancer7 recruiting
- Chronic lymphocytic leukaemia6 recruiting
- Glioblastoma6 recruiting
- Mantle cell lymphoma6 recruiting
- Follicular lymphoma5 recruiting
- Brain metastases3 recruiting
- Amyloidosis2 recruiting
- Neuroendocrine tumours2 recruiting
- Coronary artery disease1 recruiting
- Cytomegalovirus infection1 recruiting
- Epilepsy1 recruiting
- Giant cell arteritis1 recruiting
- Hodgkin lymphoma1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Liver cirrhosis1 recruiting
- Lupus (SLE)1 recruiting
- Meningioma1 recruiting
- Myocarditis1 recruiting
- Polymyalgia rheumatica1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Terminated
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
Terminated
Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
Withdrawn
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Terminated
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Completed
Terminated
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
Terminated
Completed
Terminated
Terminated
Terminated
Terminated
Terminated
Completed
Terminated
Withdrawn
mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Terminated
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Completed
Completed
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Terminated
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
Completed
Terminated
Terminated
Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.
Terminated
Terminated
Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
Completed
PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery
Withdrawn
Withdrawn
Terminated
A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
Terminated
Completed
Terminated
Terminated
Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
Terminated
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
Completed
Terminated
Completed
Terminated
Terminated
Completed
Terminated
Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Withdrawn
Terminated
Completed
Terminated
Terminated
Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients
Completed
Terminated
Completed
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Showing 50 of 165.
Site data: ClinicalTrials.govUpdated 18 Nov 2026